Daniel R. Hinthorn

1.4k total citations
46 papers, 989 citations indexed

About

Daniel R. Hinthorn is a scholar working on Epidemiology, Infectious Diseases and Pharmacology. According to data from OpenAlex, Daniel R. Hinthorn has authored 46 papers receiving a total of 989 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Epidemiology, 19 papers in Infectious Diseases and 9 papers in Pharmacology. Recurrent topics in Daniel R. Hinthorn's work include Antibiotics Pharmacokinetics and Efficacy (8 papers), Antifungal resistance and susceptibility (5 papers) and Herpesvirus Infections and Treatments (5 papers). Daniel R. Hinthorn is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (8 papers), Antifungal resistance and susceptibility (5 papers) and Herpesvirus Infections and Treatments (5 papers). Daniel R. Hinthorn collaborates with scholars based in United States, Taiwan and Vietnam. Daniel R. Hinthorn's co-authors include Chien Liu, Susan K. Pingleton, Ralph D. Feigin, Penelope G. Shackelford, Michael Luchi, James D. Cherry, Louis A. Lobes, Mazen S. Bader, Sung C. Choi and James D. Cherry and has published in prestigious journals such as JAMA, Clinical Infectious Diseases and Radiology.

In The Last Decade

Daniel R. Hinthorn

45 papers receiving 854 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel R. Hinthorn United States 17 434 194 183 152 140 46 989
Frederic Gómez‐Bertomeu Spain 21 790 1.8× 341 1.8× 153 0.8× 67 0.4× 246 1.8× 73 1.6k
I Mura Italy 20 360 0.8× 271 1.4× 183 1.0× 269 1.8× 92 0.7× 60 1.1k
Mustafa Hacımustafaoğlu Türkiye 20 618 1.4× 286 1.5× 199 1.1× 104 0.7× 77 0.6× 106 1.2k
H Grant Stiver Canada 23 599 1.4× 300 1.5× 65 0.4× 222 1.5× 42 0.3× 60 1.4k
H. Dele Davies Canada 26 1.3k 2.9× 348 1.8× 199 1.1× 136 0.9× 70 0.5× 52 2.4k
Michael Sands United States 20 530 1.2× 239 1.2× 111 0.6× 176 1.2× 164 1.2× 44 1.2k
Mirjana Nesin United States 27 745 1.7× 489 2.5× 316 1.7× 52 0.3× 61 0.4× 54 1.8k
Joseph B. Cantey United States 22 812 1.9× 278 1.4× 293 1.6× 117 0.8× 126 0.9× 67 1.7k
John C. Christenson United States 20 751 1.7× 404 2.1× 329 1.8× 153 1.0× 145 1.0× 60 1.5k
Nuran Salman Türkiye 18 449 1.0× 517 2.7× 154 0.8× 148 1.0× 29 0.2× 92 1.2k

Countries citing papers authored by Daniel R. Hinthorn

Since Specialization
Citations

This map shows the geographic impact of Daniel R. Hinthorn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel R. Hinthorn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel R. Hinthorn more than expected).

Fields of papers citing papers by Daniel R. Hinthorn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel R. Hinthorn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel R. Hinthorn. The network helps show where Daniel R. Hinthorn may publish in the future.

Co-authorship network of co-authors of Daniel R. Hinthorn

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel R. Hinthorn. A scholar is included among the top collaborators of Daniel R. Hinthorn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel R. Hinthorn. Daniel R. Hinthorn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Newman, Jessica, et al.. (2020). 25. Effectiveness of High Dose Influenza Vaccine in HIV-positive Patients for the Winter 2017–2018 Season. Open Forum Infectious Diseases. 7(Supplement_1). S36–S37. 1 indexed citations
2.
Fraga, Garth, et al.. (2015). Lues maligna praecox: an important consideration in HIV-positive patients with ulceronodular skin lesions. Dermatology Online Journal. 21(3). 4 indexed citations
3.
Hawkinson, Dana, Daniel R. Hinthorn, & Lara Danziger‐Isakov. (2013). Novel Antiviral Agents for Respiratory Viral Infection in Immunocompromised Adults. Current Infectious Disease Reports. 15(6). 497–503. 1 indexed citations
4.
Hammoud, Kassem, et al.. (2009). Bloody Diarrhea Caused by Infection With Klebsiella oxytoca in a Burn Patient. 26(5). 154–156. 2 indexed citations
5.
Bader, Mazen S., Daniel R. Hinthorn, Sue Min Lai, & Edward F. Ellerbeck. (2005). Hyperglycaemia and mortality of diabetic patients with candidaemia. Diabetic Medicine. 22(9). 1252–1257. 14 indexed citations
6.
Myers, Stephen, et al.. (2005). Life-Threatening Maternal and Fetal Macrocytic Anemia From Antiretroviral Therapy. Obstetrics and Gynecology. 106(5). 1189–1191. 3 indexed citations
7.
Hinthorn, Daniel R., et al.. (2002). Pharmacist Scope of Practice: Response to Position Paper. Annals of Pharmacotherapy. 36(4). 718–720. 3 indexed citations
8.
Estes, Norman, et al.. (1998). Carcinoma of the Colon: An Unusual Cause of Prolonged Fever. Southern Medical Journal. 91(5). 462–463. 3 indexed citations
9.
Hinthorn, Daniel R., et al.. (1996). Intermittent Enteral Feeding in Mechanically Ventilated Patients. CHEST Journal. 110(1). 243–248. 45 indexed citations
10.
Whitley, Richard J., J. W. Gnann, Daniel R. Hinthorn, et al.. (1992). Disseminated Herpes Zoster in the Immunocompromised Host: A Comparative Trial of Acyclovir and Vidarabine. The Journal of Infectious Diseases. 165(3). 450–455. 66 indexed citations
11.
Wang, Lih-Shinn, et al.. (1990). Nonenterococcal Group D Streptococcal Septicemia: Association with Unrecognized Endocarditis. Scandinavian Journal of Infectious Diseases. 22(6). 681–690. 2 indexed citations
12.
Liu, Chun‐Yu, et al.. (1990). Klebsiella pneumoniae bacteremia: analysis of 100 episodes.. PubMed. 89(9). 756–63. 36 indexed citations
13.
Hinthorn, Daniel R., et al.. (1990). Short-course treatment of bacteremia with ceftriaxone monotherapy.. PubMed. 89(2). 115–20. 2 indexed citations
14.
Hinthorn, Daniel R., et al.. (1989). Successful treatment of progressive disseminated histoplasmosis with amphotericin B methyl ester. Diagnostic Microbiology and Infectious Disease. 12(1). 17–19. 1 indexed citations
15.
Hinthorn, Daniel R., et al.. (1988). Cure of Brain Abscess Caused by Nocardia asteroides Resistant to Multiple Antibiotics. Southern Medical Journal. 81(3). 412–413. 17 indexed citations
16.
Hinthorn, Daniel R., et al.. (1983). pH-Dependent Accumulation of Clindamycin in a Polycystic Kidney. American Journal of Kidney Diseases. 3(1). 63–66. 33 indexed citations
17.
Hinthorn, Daniel R., et al.. (1979). Penetration of Cefoxitin into Human Cerebrospinal Fluid: Comparison with Cefamandole, Ampicillin, and Penicillin. Clinical Infectious Diseases. 1(1). 127–131. 21 indexed citations
18.
Hinthorn, Daniel R., et al.. (1978). Nafcillin-Associated Granulocytopenia. Southern Medical Journal. 71(11). 1356–1358. 10 indexed citations
19.
Cherry, James D., et al.. (1973). A clinical and serologic study of 103 children with measles vaccine failure. The Journal of Pediatrics. 82(5). 802–808. 75 indexed citations
20.
Cherry, James D., Ralph D. Feigin, Louis A. Lobes, et al.. (1972). Urban measles in the vaccine era: A clinical, epidemiologic, and serologic study. The Journal of Pediatrics. 81(2). 217–230. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026